Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rassf4 | Rat | (+)-catechin | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RASSF4 mRNA | CTD | PMID:24763279 | Rassf4 | Rat | (-)-demecolcine | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of RASSF4 mRNA | CTD | PMID:23649840 | Rassf4 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of RASSF4 mRNA | CTD | PMID:22206623 | Rassf4 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of RASSF4 mRNA | CTD | PMID:25380136 | Rassf4 | Rat | 17beta-estradiol | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of RASSF4 mRNA | CTD | PMID:20660070 | Rassf4 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Rassf4 | Rat | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Rassf4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RASSF4 mRNA | CTD | PMID:22298810 | Rassf4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RASSF4 mRNA | CTD | PMID:34747641 | Rassf4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RASSF4 mRNA | CTD | PMID:25975270 | Rassf4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rassf4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RASSF4 mRNA | CTD | PMID:21570461 | Rassf4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RASSF4 mRNA | CTD | PMID:22298810 | Rassf4 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Rassf4 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | Rassf4 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF4 mRNA more ... | CTD | PMID:28628672 | Rassf4 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of RASSF4 mRNA | CTD | PMID:25380136 | Rassf4 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of RASSF4 mRNA | CTD | PMID:28973697 | Rassf4 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of RASSF4 mRNA | CTD | PMID:22504374 | Rassf4 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of RASSF4 mRNA | CTD | PMID:24780913 | Rassf4 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of RASSF4 mRNA | CTD | PMID:31881176 | Rassf4 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of RASSF4 mRNA | CTD | PMID:28959563 | Rassf4 | Rat | acrylamide | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of RASSF4 mRNA | CTD | PMID:32763439 | Rassf4 | Rat | actinomycin D | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of RASSF4 mRNA | CTD | PMID:38460933 | Rassf4 | Rat | aflatoxin B1 | increases methylation | ISO | RASSF4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of RASSF4 intron | CTD | PMID:30157460 | Rassf4 | Rat | all-trans-retinoic acid | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RASSF4 mRNA | CTD | PMID:21934132 and PMID:33167477 | Rassf4 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RASSF4 mRNA | CTD | PMID:36189433 | Rassf4 | Rat | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of RASSF4 mRNA | CTD | PMID:20488242 | Rassf4 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of RASSF4 mRNA | CTD | PMID:30779732 | Rassf4 | Rat | antirheumatic drug | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of RASSF4 mRNA | CTD | PMID:24449571 | Rassf4 | Rat | benzo[a]pyrene | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RASSF4 mRNA | CTD | PMID:22228805 | Rassf4 | Rat | benzo[a]pyrene | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RASSF4 mRNA | CTD | PMID:19770486 and PMID:22610609 | Rassf4 | Rat | benzo[e]pyrene | increases methylation | ISO | RASSF4 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of RASSF4 intron | CTD | PMID:30157460 | Rassf4 | Rat | beta-naphthoflavone | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of RASSF4 mRNA | CTD | PMID:32858204 | Rassf4 | Rat | bilirubin IXalpha | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Bilirubin results in increased expression of RASSF4 mRNA | CTD | PMID:20196124 | Rassf4 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA | CTD | PMID:31199487 | Rassf4 | Rat | bisphenol A | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of RASSF4 mRNA | CTD | PMID:26063408 and PMID:30951980 | Rassf4 | Rat | bisphenol A | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of RASSF4 mRNA | CTD | PMID:36232920 | Rassf4 | Rat | bisphenol A | decreases methylation | ISO | RASSF4 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of RASSF4 gene | CTD | PMID:31601247 | Rassf4 | Rat | bisphenol A | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF4 mRNA | CTD | PMID:28628672 | Rassf4 | Rat | bisphenol A | decreases methylation | ISO | Rassf4 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of RASSF4 promoter | CTD | PMID:27312807 | Rassf4 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RASSF4 mRNA | CTD | PMID:25181051 | Rassf4 | Rat | bisphenol F | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASSF4 mRNA | CTD | PMID:28628672 | Rassf4 | Rat | bisphenol F | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | bisphenol F results in increased expression of RASSF4 mRNA | CTD | PMID:30951980 | Rassf4 | Rat | buta-1,3-diene | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of RASSF4 mRNA | CTD | PMID:29038090 | Rassf4 | Rat | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA | CTD | PMID:31199487 | Rassf4 | Rat | CGP 52608 | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RASSF4 gene] | CTD | PMID:28238834 | Rassf4 | Rat | choline | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASSF4 mRNA | CTD | PMID:20938992 | Rassf4 | Rat | cisplatin | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of RASSF4 mRNA | CTD | PMID:27392435 | Rassf4 | Rat | cisplatin | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of RASSF4 mRNA | CTD | PMID:27392435 | Rassf4 | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of RASSF4 mRNA | CTD | PMID:24386269 | Rassf4 | Rat | copper(II) sulfate | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of RASSF4 mRNA | CTD | PMID:19549813 | Rassf4 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of RASSF4 mRNA | CTD | PMID:27523638 | Rassf4 | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of RASSF4 mRNA | CTD | PMID:26577399 | Rassf4 | Rat | cyclosporin A | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of RASSF4 mRNA | CTD | PMID:20106945 more ... | Rassf4 | Rat | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of RASSF4 mRNA | CTD | PMID:23914054 | Rassf4 | Rat | dexamethasone | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of RASSF4 mRNA | CTD | PMID:22733784 | Rassf4 | Rat | dexamethasone | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF4 mRNA more ... | CTD | PMID:28628672 | Rassf4 | Rat | dexamethasone | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of RASSF4 mRNA | CTD | PMID:25047013 | Rassf4 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of RASSF4 mRNA | CTD | PMID:21266533 | Rassf4 | Rat | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA | CTD | PMID:31199487 | Rassf4 | Rat | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA | CTD | PMID:31199487 | Rassf4 | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of RASSF4 mRNA | CTD | PMID:17005392 | Rassf4 | Rat | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA | CTD | PMID:31199487 | Rassf4 | Rat | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA | CTD | PMID:31199487 | Rassf4 | Rat | dioxygen | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of RASSF4 mRNA | CTD | PMID:26516004 | Rassf4 | Rat | dorsomorphin | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF4 mRNA | CTD | PMID:27188386 | Rassf4 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of RASSF4 mRNA | CTD | PMID:29391264 | Rassf4 | Rat | entinostat | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | entinostat results in increased expression of RASSF4 mRNA | CTD | PMID:27188386 | Rassf4 | Rat | ethanol | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Ethanol results in increased expression of RASSF4 mRNA | CTD | PMID:28986285 | Rassf4 | Rat | folic acid | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASSF4 mRNA | CTD | PMID:20938992 | Rassf4 | Rat | folic acid | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of RASSF4 mRNA | CTD | PMID:25629700 | Rassf4 | Rat | formaldehyde | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of RASSF4 mRNA | CTD | PMID:23649840 | Rassf4 | Rat | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of RASSF4 mRNA | CTD | PMID:24915197 | Rassf4 | Rat | glyphosate | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Glyphosate results in increased expression of RASSF4 mRNA | CTD | PMID:35897073 | Rassf4 | Rat | hydrogen cyanide | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Hydrogen Cyanide results in increased expression of RASSF4 mRNA | CTD | PMID:33914522 | Rassf4 | Rat | hydrogen peroxide | affects expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of RASSF4 mRNA | CTD | PMID:20044591 | Rassf4 | Rat | hypochlorous acid | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of RASSF4 mRNA | CTD | PMID:19376150 | Rassf4 | Rat | indometacin | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASSF4 mRNA more ... | CTD | PMID:28628672 | Rassf4 | Rat | isoprenaline | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of RASSF4 mRNA | CTD | PMID:20003209 | Rassf4 | Rat | ivermectin | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RASSF4 protein | CTD | PMID:32959892 | Rassf4 | Rat | L-methionine | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASSF4 mRNA | CTD | PMID:20938992 | Rassf4 | Rat | lead(0) | affects expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Lead affects the expression of RASSF4 mRNA | CTD | PMID:28903495 | Rassf4 | Rat | methapyrilene | increases methylation | ISO | RASSF4 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of RASSF4 intron | CTD | PMID:30157460 | Rassf4 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of RASSF4 mRNA | CTD | PMID:22504374 | Rassf4 | Rat | methylmercury chloride | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of RASSF4 mRNA | CTD | PMID:28001369 | Rassf4 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RASSF4 mRNA | CTD | PMID:36189433 | Rassf4 | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of RASSF4 mRNA | CTD | PMID:25380136 | Rassf4 | Rat | nickel atom | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Nickel results in increased expression of RASSF4 mRNA | CTD | PMID:24768652 and PMID:25583101 | Rassf4 | Rat | Nutlin-3 | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of RASSF4 mRNA | CTD | PMID:38460933 | Rassf4 | Rat | ozone | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RASSF4 mRNA | CTD | PMID:34911549 | Rassf4 | Rat | paracetamol | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of RASSF4 mRNA | CTD | PMID:29067470 | Rassf4 | Rat | PCB138 | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Rassf4 | Rat | potassium cyanide | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Potassium Cyanide results in increased expression of RASSF4 mRNA | CTD | PMID:33914522 | Rassf4 | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of RASSF4 mRNA | CTD | PMID:28903501 | Rassf4 | Rat | progesterone | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of RASSF4 mRNA | CTD | PMID:20660070 | Rassf4 | Rat | propanal | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of RASSF4 mRNA | CTD | PMID:26079696 | Rassf4 | Rat | propiconazole | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | propiconazole results in decreased expression of RASSF4 mRNA | CTD | PMID:21278054 | Rassf4 | Rat | protein kinase inhibitor | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RASSF4 mRNA] | CTD | PMID:28003376 | Rassf4 | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of RASSF4 mRNA | CTD | PMID:25905778 | Rassf4 | Rat | SB 431542 | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF4 mRNA | CTD | PMID:27188386 | Rassf4 | Rat | silicon dioxide | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of RASSF4 mRNA | CTD | PMID:25895662 | Rassf4 | Rat | sodium arsenite | affects methylation | ISO | RASSF4 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of RASSF4 gene | CTD | PMID:28589171 | Rassf4 | Rat | sodium arsenite | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RASSF4 mRNA | CTD | PMID:29301061 | Rassf4 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of RASSF4 mRNA | CTD | PMID:19281266 | Rassf4 | Rat | succimer | multiple interactions | ISO | Rassf4 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RASSF4 mRNA | CTD | PMID:21641980 | Rassf4 | Rat | sunitinib | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of RASSF4 mRNA | CTD | PMID:31533062 | Rassf4 | Rat | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of RASSF4 mRNA | CTD | PMID:26141394 | Rassf4 | Rat | tetraphene | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | benz(a)anthracene results in decreased expression of RASSF4 mRNA | CTD | PMID:26377693 | Rassf4 | Rat | thimerosal | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of RASSF4 mRNA | CTD | PMID:27188386 | Rassf4 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of RASSF4 mRNA | CTD | PMID:34492290 | Rassf4 | Rat | titanium dioxide | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of RASSF4 mRNA | CTD | PMID:23557971 | Rassf4 | Rat | titanium dioxide | decreases methylation | ISO | Rassf4 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of RASSF4 gene | CTD | PMID:35295148 | Rassf4 | Rat | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of RASSF4 mRNA | CTD | PMID:30012374 | Rassf4 | Rat | titanium dioxide | decreases expression | ISO | Rassf4 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of RASSF4 mRNA | CTD | PMID:27760801 | Rassf4 | Rat | trichostatin A | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of RASSF4 mRNA | CTD | PMID:24935251 and PMID:26272509 | Rassf4 | Rat | trichostatin A | multiple interactions | ISO | RASSF4 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF4 mRNA | CTD | PMID:27188386 | Rassf4 | Rat | triptonide | increases expression | ISO | Rassf4 (Mus musculus) | 6480464 | triptonide results in increased expression of RASSF4 mRNA | CTD | PMID:33045310 | Rassf4 | Rat | urethane | decreases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Urethane results in decreased expression of RASSF4 mRNA | CTD | PMID:28818685 | Rassf4 | Rat | valproic acid | increases methylation | ISO | RASSF4 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of RASSF4 gene | CTD | PMID:29154799 | Rassf4 | Rat | valproic acid | affects expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RASSF4 mRNA | CTD | PMID:25979313 | Rassf4 | Rat | valproic acid | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of RASSF4 mRNA | CTD | PMID:27188386 | Rassf4 | Rat | vincristine | increases expression | ISO | RASSF4 (Homo sapiens) | 6480464 | Vincristine results in increased expression of RASSF4 mRNA | CTD | PMID:23649840 | |